Cost-utility Analysis of Ambulatory Care Compared to Conventional Patient Care of Permanent Pacemakers Replacement for Elective Replacement Indicator (START)

March 12, 2019 updated by: Nantes University Hospital

START study is a comparison of cost-utility between permanent pacemaker replacement ambulatory care and permanent pacemaker replacement conventional hospitalization care.

The hypothesis of the study is that ambulatory care compared to conventional hospitalization, involving a stay of more than 24 hours, would reduce hospitalization and care expenses without loss of quality of care and without increasing the complication rate for patients.

Study Overview

Detailed Description

In France, nearly 49,000 permanent pacemakers are implanted each year. The pacemaker longevity is about 10 years which leads to their replacement.

In France, in 2016, 15,764 pacemaker replacement hospital stays took place. 10.6% of them were made during an outpatient stay, 12.4% during a one-night hospitalization and 70.7% during hospitalization for two or more than two nights for the severity level 1.

If the outpatient care management is deployed at 90%, the economy of the cost care will be estimated to be 3,5 million euros and a reduction of 15 582 hospitalization night's stay.

The aim of START study is to compare cost-utility between ambulatory and conventional hospitalization care of permanent pacemakers replacement for elective replacement indicator and to demonstrate equivalence between outpatient management and conventional hospitalization management.

This study is in adequation with the national ambition to deploy the outpatient management in France. Surgery is the same with both hospitalization managements.

An ambulatory surgery need to present different advantages and benefits like high quality care and substantial cost savings.

The benefits of ambulatory care management are :

  • An economy of hospitalization nights cost.
  • A decrease in health costs related to the surgery realization.
  • Patient satisfaction expected due to hospital discharged within 24 hours. Patient is expected to go home the same day as the surgery with good perception of ambulatory surgery.
  • A decrease in the disorientation risk in the elderly patient is also expected.

Surgery is the same with both hospitalization managements.

Patients will be randomized in 2 arms. An arm conventional hospitalization management (control arm) and an arm outpatient care management.

Study period is 30 months. Patients will be following during 6 months. The recruitment time will be 24 months.

Study Type

Interventional

Enrollment (Anticipated)

750

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49933
        • Angers University Hospital
      • Brest, France, 29200
        • Brest University Hospital
      • Dijon, France, 21079
        • Dijon University Hospital
      • Grenoble, France, 38000
        • Grenoble University Hospital
      • Marseille, France, 13005
        • AP-HM
      • Montpellier, France, 34295
        • Montpellier University Hospital
      • Nancy, France, 54511
        • Nancy University Hospital
      • Paris, France, 75013
        • AP-HP, La Pitié Salpétrière
      • Rennes, France, 35033
        • Rennes University Hospital
      • Saint-Étienne, France, 42100
        • Saint-Etienne University Hospital
      • Strasbourg, France
        • Strasbourg University Hospital
      • Toulouse, France, 31059
        • Toulouse University Hospital
      • Tours, France, 37044
        • Tours University Hopsital
    • Bron
      • Lyon, Bron, France, 69677
        • Lyon University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Man or woman over 18 years old.
  • Replacement of permanent pacemakers for battery elective wear without programmed act in the sensors regardless of pacemaker type, simple, dual or triple chambers and regardless pacemaker label.
  • Patient living less than an hour from a hospital center
  • Patient is able to answer the phone.
  • Patient has an accompaniment the go out night
  • Pacemaker-dependent patient or not regardless of indication of placement of the pacemaker
  • Patient with or without anticoagulant treatment: the anticoagulant treatment is managed by center under these habits.
  • Patient has given this free and informed consent.
  • Patient having insurance in France.

Exclusion Criteria:

  • Ambulatory Hospitalization is impossible.
  • Patient refuses to participate
  • Patient has hemostasis disorder yielding ambulatory hospitalization impossible.
  • Woman is pregnant, nursing mothers or the patient don't receive an effective contraception.
  • Patient under guardianship, safeguard of justice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: conventional hospitalization management.

The patients who are randomized to have a conventional hospitalization for the pacemaker replacement have conventional management.

In this management patient come to hospital one day before this surgical operation and he is operated next day

START's intervention is a replacement of permanent pacemakers for elective wear, for the both arms the surgical intervention is the same. The surgical procedure is the same in the both arms.

The differences are in conventional hospitalization, patient comes to hospital one day before operation and he can go out one day after operation. In ambulatory patient come to hospital operation days and he can got out the same day.

Active Comparator: ambulatory management

The patients who are randomized to have a ambulatory surgery for the pacemaker replacement have ambulatory management.

In the ambulatory hospitalization patients come to hospital and have a surgical operation the same day

START's intervention is a replacement of permanent pacemakers for elective wear, for the both arms the surgical intervention is the same. The surgical procedure is the same in the both arms.

The differences are in conventional hospitalization, patient comes to hospital one day before operation and he can go out one day after operation. In ambulatory patient come to hospital operation days and he can got out the same day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost-utility analysis,from the perspective of the society and a time horizon of 6 months,of ambulatory management compared to the intervention in conventional hospitalization of a replacement,for elective wear,permanent pacemakers
Time Frame: 6 month
Incremental cost-utility ratio (cost by quality-adjusted life-years, QALY) of outpatient management compared to compared to the intervention in conventional hospitalization (≥1 night) of a replacement, for elective wear, permanent pacemakers. This analysis is from the perspective of the society and a time horizon of 6 months.
6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess, the point of view of health insurance and health care institutions with a time horizon of 5 years, the annual and global budgetary impact in € of different diffusion scenarios for ambulatory to replace conventional hospitalization
Time Frame: on a time horizon of 5 years
Annual and global net profit cost in € of different diffusion scenarios for ambulatory to replace conventional hospitalization.
on a time horizon of 5 years
Evaluate and compare the rate of complications of different management within 6 months after the intervention in both arms.
Time Frame: on time horizon of 6 months
Complication statement requiring a rehospitalization with reoperation. This objective is assessed by the complication statement requiring rehospitalization without reoperation and complication with not requiring rehospitalization.
on time horizon of 6 months
Evaluate the ambulatory failure rate
Time Frame: during all the study, during 30 months.
Ambulatory failure rate. It is a ratio of the number of ambulatory visits converted to conventional hospitalization and the total number of ambulatory visits.
during all the study, during 30 months.
Evaluate and compare patients satisfaction between intervention and hospital management in both arms
Time Frame: during hospitalization, during 2 days
Satisfaction with the intervention and management at the hospital with questionnaire
during hospitalization, during 2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vincent Probst, Nantes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2019

Primary Completion (Anticipated)

April 1, 2022

Study Completion (Anticipated)

April 1, 2022

Study Registration Dates

First Submitted

February 14, 2019

First Submitted That Met QC Criteria

March 12, 2019

First Posted (Actual)

March 15, 2019

Study Record Updates

Last Update Posted (Actual)

March 15, 2019

Last Update Submitted That Met QC Criteria

March 12, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe